Clinical Trials Logo

Lidocaine clinical trials

View clinical trials related to Lidocaine.

Filter by:

NCT ID: NCT04858711 Recruiting - Pain, Postoperative Clinical Trials

Opioid-free Anesthesia With a Mixture of Dexmedetomidine-lidocaine-ketamine

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study will be to investigate the effect of an opioid-free anesthesia regimen with a mixture of dexmedetomidine-lidocaine-ketamine in the same syringe versus fentanyl analgesia in elective laparoscopic gynecological surgery

NCT ID: NCT04622904 Recruiting - Pain, Postoperative Clinical Trials

Lidocaine and Magnesium and Ketamine in Gynecological Surgery

annie-sophia
Start date: November 14, 2020
Phase: N/A
Study type: Interventional

The aim of this study will be to investigate the effect of a combination of intravenous infusions of lidocaine and magnesium versus a combination of intravenous infusions of lidocaine and ketamine versus an intravenous infusion of lidocaine alone on recovery profile, quality of recovery and postoperative pain after elective gynecological surgery

NCT ID: NCT04169854 Recruiting - Postoperative Pain Clinical Trials

Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain

EASY
Start date: October 15, 2020
Phase: Phase 3
Study type: Interventional

Postcraniotomy pain remains a common phenomenon in the neurosurgery field. Managements for postcraniotomy pain are to be standardised and optimized. In the proposed study, the investigators aim to provide a novel regional non-invasive prophylactic strategy for postcraniotomy pain by utilizing Lidocaine 5% plaster.

NCT ID: NCT04144933 Recruiting - Anesthesia Clinical Trials

Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery

RUMBLE
Start date: May 15, 2021
Phase: Phase 3
Study type: Interventional

The objective of this study is to determine if an opioid-free general anesthetic (OFA) technique utilizing lidocaine, ketamine, dexmedetomidine and magnesium reduce postoperative opioid consumption and speed return of bowel function in patients undergoing elective, laparoscopic, colorectal surgery compared to traditional opioid-containing general anesthetic techniques. It is hypothesized that this intraoperative OFA regimen will reduce postoperative opioid consumption, and expedite return of bowel function in this population.

NCT ID: NCT03984656 Recruiting - Analgesia Clinical Trials

Evaluation of the Analgesia by Serratus Plane Block During Pleural Drainage in Intensive Care Unit.

SERRATUS
Start date: June 4, 2019
Phase: Phase 3
Study type: Interventional

Pleural drainage under local anesthesia is a frequent practice in resuscitation, experienced as an unpleasant and painful event for patients. Pain management is an important issue for early rehabilitation, decrease hospitalisation's cost and shortening the length of stay in intensive care unit (ICU). A new type of locoregional anesthesia called Serratus plane block described by Blanco in 2013 showed a benefit in per and postoperative analgesia in thoracic surgery and carcinologic breast surgery, allowing a decrease in morphine use and an improvement of the patient's general satisfaction. Serratus plane block is a very effective technique in chest wall analgesia, easy and safe to perform, with few complications. No studies to date have evaluated this anesthetic practice in intensive care for pleural drainage. This technique could be used outside the operating room to improve the intensive care patients, who often have heavier pathologies and greater pain, such as patients with chest trauma or patients with cardiac or respiratory disease. The investigators would like to conduct a preliminary study of superiority in the CHU Amiens intensive care unit, to study the interest of the Serratus plane block in comparison with local anesthesia on the management of acute pain during pleural drainage.

NCT ID: NCT03871478 Recruiting - Lidocaine Clinical Trials

Comparing the Efficacy of Local Anesthetics in Mohs Surgery

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Mohs surgery is a very effective option in removing non-melanoma skin cancers, as the tissue being removed is analyzed the same day. If there are remnants of cancer cells in the tissue removed, the Mohs surgeon will go back and remove further tissue and repair the surgical wound all within the same day. Unfortunately, postoperative pain is quite prevalent among patients requiring Mohs procedures, as up to 52% require an additional oral pain medication. Lidocaine is the most commonly used anesthetic used in Mohs given its rapid onset of action. However, the duration of lidocaine's effect is much shorter than bupivacaine, which may translate into increased postoperative pain. To date, there are no specific studies comparing bupivacaine alone, lidocaine alone or both in conjunction in Mohs procedures. The investigators predict bupivacaine alone and bupivacaine used in conjunction with lidocaine are more effective in managing pain during Mohs surgery than lidocaine alone. To test our hypothesis, the investigators plan to have 105 patients receive either lidocaine alone, bupivacaine alone, or lidocaine and bupivacaine in conjunction during their Mohs procedure. Pain will be evaluated at various time points throughout the surgery.

NCT ID: NCT03731429 Recruiting - Lidocaine Clinical Trials

Lidocaine to Prevent Cough and Hemodynamic Changes in Tracheal Extubation

Start date: April 5, 2019
Phase: Phase 4
Study type: Interventional

Coughing during tracheal extubation can be associated to adverse effects like tachycardia, arterial hypertension (AHT), increase of intracranial pressure (ICP) and intraocular pressure (IOP), and the dehiscence of surgical wounds. In ophthalmic, head and neck, and abdominal surgery, and in several other neurosurgical interventions it is vital to prevent these effects. The incidence of laryngeal irritation due to orotracheal intubation hinders patient comfort in the immediate postoperative (POP) period and no pharmacological intervention has been yet proven to prevent it. At the end of the surgical procedure, the depth of the anesthetic plane decreases with the concomitant suspension of the anesthetic agents. However, the patient still requires ventilatory support through the endotracheal tube (EDT). The physical stimulation of the trachea created by this foreign body leads to the activation of the sympathetic nervous system, expressed in AHT, tachycardia, and ICP. To tolerate the EDT and prevent these effects, different maneuvers have been tested such as extubating the patient in a deep anesthetic plane or administering intravenous (IV) narcotics with the entailed complications: airway (AW) obstruction and hypercapnia, and the aspiration of an unprotected AW. Progress has been made with the introduction of ultrashort acting opioids, with significant statistical results. Moreover, beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and dexmedetomidine have been used to decrease the hemodynamic impact associated to tracheal extubation. The use of both IV and intratracheal lidocaine in doses ranging from 1 mg/kg to 3 mg/kg, has been studied with controversial results. In view of the above, and as lidocaine is the most commonly used low-cost drug in all operating rooms with a good safety profile when used at low doses, the purpose of this study is twofold: to assess its effects at reducing coughing and to evaluate its hemodynamic impact when administering IV 1 mg/kg prior to extubation. Then, the efficiency of reducing the incidence of sore throats after the immediate POP shall be investigated.

NCT ID: NCT03673163 Recruiting - Chronic Pain Clinical Trials

Lidocaine Infusion for Pain After Herniotomy

LIPAH
Start date: November 6, 2018
Phase: N/A
Study type: Interventional

This study seeks to investigate lidocaine infusion to reduce occurrence of chronic postoperative pain at 3-month after inguinal herniotomy

NCT ID: NCT03666299 Recruiting - Chronic Pain Clinical Trials

Lidocaine Infusion for Postthoracotomy Pain Syndrome

LIPPS
Start date: November 6, 2018
Phase: N/A
Study type: Interventional

This study seeks to investigate lidocaine infusion to reduce postthoractomy pain syndrome after thoracic Surgery